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The seminal work of Paul E. Meehl on schizotaxia, the genetic
predisposition or the unexpressed liability to schizophrenia spectrum
disorders (Meehl, 1962), opened the doors to a new view of these
disorders and to the determination of its core features. In subsequent
reformulations of schizotaxia (Meehl, 1989, 1990, 1993), the notion
was defined as a latent central nervous system integrative defect,
derived from a genetic aberration in the neuron’s synaptic signal
selectivity (hypokrisia), and characterized by its influence on
multiple psychophysiologic and soft neurologic indicators, and by
parametric aberrations in the acquisition and activation of diverse
molar psychological functions (perceptual-cognitive, semantic,
motivational, and affective). Allegedly, schizotaxia or the subtle
neural integrative defect, inherited endophenotype, could result in
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This study falls within research on schizotaxia, or neurocognitive risk markers of schizophrenia
spectrum disorders, and its usefulness for early prevention strategies. Two samples of 60 adults and 65
children and adolescents, with some genetic or psychosocial high-risk individuals among them, were
examined to compare the relationship between schizotypy dimensions and risk factors, and
neurocognitive performance. One of the most practical aspects of this study was the proposal of a
combined and straightforward measure of liability to schizophrenia spectrum disorders, in contrast to
the current high availability of neurocognitive markers. For that purpose, several psychometric
analyses were made exploring schizotypy dimensions, as well as 16 measures of cortical functions
(executive, attentional, working memory and general cognitive functioning tasks) in adults and 20
measures in adolescents. In keeping with previous research, our results hypothetically indicate that the
most accurate measure of schizotaxia combines negative traits of schizotypy, in the range of percentile
90 or higher in the Introvertive Anhedonia subscale of the O-LIFE or percentile 85 or higher in the
Negative Schizotypy subscale of the MSTQ and, on the other hand, a score of 5 or higher in a
combined neurocognitive deficit scale in adults and 6 or higher in adolescents (the number of measures
exceeding the threshold of deficit of the distribution scores). Moreover, some other independent
measures of clinical and social function, and follow-up studies, are necessary to confirm the predictive
validity of this measure of schizotaxia.
Medida combinada para la detección de la esquizotaxia. El trabajo se inserta en las investigaciones
sobre esquizotaxia o los marcadores neurocognitivos de riesgo para los trastornos del espectro
esquizofrénico y su utilidad para la prevención temprana. Se valoraron dos muestras de 60 adultos y
65 adolescentes, entre quienes se encuentran sujetos de alto riesgo genético y psicosocial, con el fin de
comparar la relación existente entre las dimensiones de esquizotipia y los factores de riesgo, y el
rendimiento neurocognitivo. Un aspecto práctico de este estudio es la propuesta de una medida sencilla
y combinada de predisposición a los trastornos del espectro esquizofrénico, en vez de manejar el alto
número de marcadores neurocognitivos de los que actualmente se dispone. Con este propósito, se
llevaron a cabo diversos análisis psicométricos para explorar las dimensiones de esquizotipia, y se
obtuvieron 16 medidas de funciones corticales (tareas ejecutivas, atencionales, de memoria operativa
y de funcionamiento cognitivo general) en adultos y 20 medidas en adolescentes. En consonancia con
investigaciones anteriores, nuestros resultados hipotéticamente indican que la medida más precisa de
esquizotaxia puede incluir la combinación, por un lado, de rasgos negativos de esquizotipia, con una
puntuación equivalente al percentil 90 o superior en la subescala de Anhedonia Introvertida del O-
LIFE o al percentil 85 o superior en la subescala de Esquizotipia Negativa del MSTQ y, por el otro,
una puntuación igual o superior a 5 en una escala combinada de déficit neurocognitivo en adultos, e
igual o superior a 6 en adolescentes (es decir, el número de medidas que superan el umbral de déficit
de la distribución de puntuaciones). No obstante, se considera necesario confirmar la validez predictiva
de esta medida de esquizotaxia con otras medidas independientes y longitudinales del funcionamiento
clínico y social.
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either a moderate outcome (the schizotypal personality structure) or
a more severe outcome (the schizophrenia), depending on the
protection and social reinforcement factors or risk environmental
circumstances. Meehl conjectured that schizophrenia is not primary
a mental disorder but a neurologic disorder of genetic origin.
Accordingly, Meehl views schizotaxia as a neurophysiological
basis for what Bleuler considered a core psychological trait (the
associative loosening), that could result by social learning processes
in schizotypal personality and that, once developed, is permanent
but existing like other physical disorders (e.g., diabetes, gout,
cardiac disease) in varying degrees of clinical compensation. The
compensated schizotype, the decompensated, the disintegrated, and
the deteriorated states are not disjunctive but successively inclusive
categories, in Meehl`s opinion; and schizophrenia, as a major
psychological complication, is found in a minority (estimated in
about 10 percent) of cases (Meehl, 2001). As Meehl points out, the
absence of an only and necessary marker of the genetic
predisposition to schizophrenia spectrum disorders makes sense to
take into account a combination of deviant scores on several
indicators (signs and symptoms, neuropsychological performance,
and psychosocial functioning), and to apply taxometric statistical
procedures in the study of the premorbid neurological substrate or
latent liability (Meehl, 1995; Meehl, 1992).
Some other researches (Faraone, Green, Seidman & Tsuang,
2001; Tsuang, Stone & Faraone, 2000; Tsuang, Stone, Tarbox &
Faraone, 2002) have recently retained the core notion of
schizotaxia introduced by Meehl, as a neural integrative defect, but
reformulated the condition with the following differences: (a) they
consider its etiology to derive from both a genetic factor and from
biological consequences of adverse environmental factors (such as
pregnancy or delivery complications), whereas Meehl proposed
that the etiology was solely genetic; (b) they believe that
schizotaxia reflects a multifactorial poligenic etiology, while Meehl
thought it reflected the effects of a single, major gene; (c) they view
many outcomes of the stable condition of schizotaxia, beside the
only and most likely disorders of schizotypy or schizophrenia
viewed by Meehl; and (d) unlike Meehl, they have begun to
identify the components of schizotaxia, and to operationalize the
concept, based on psychiatric signs (mild negative symptoms) and
neuropsychological attributes found in first-degree relatives of
schizophrenia patients.
To summarize the authors’ knowledge (Faraone et al., 2001;
Faraone, Kremen et al., 1995; Faraone, Seidman et al., 1995),
schizotaxia and negative schizotypy are similar, and may describe
the same syndrome. The schizotaxic subjects show significantly
high ratings on negative (e.g., social isolation, interpersonal
dysfunction, impoverished affective experiences or restricted
emotion, and anhedonia) but not positive symptoms (e.g., ideas of
reference, magical thinking, illusions and psychotic-like
phenomena), and deficits in multiple cognitive domains (e.g., long-
term verbal memory, attention, working memory, and/or executive
functions). Accordingly, such studies designate schizotaxia as the
syndrome of negative symptoms and neurocognitive dysfunction
observed among relatives of schizophrenia patients, while they view
schizotypal personality disorder as the heterogeneous
schizophrenia-like syndrome, derived from clinical and family
research methods (Kendler, 1985), in which positive symptoms
dominate the clinical picture. Schizotypy is considered the
«entrance door» to schizophrenia, where positive symptoms are also
the target of current cognitive-behavioural interventions (Cuevas-
Yust, Perona-Garcelán & Martínez-López, 2003; Perona Garcelán
& Cuevas Yust, 2002; Turkington, Kingdon & Chadwick, 2003).
Consistent with several studies, the core features of schizotaxia
(negative symptoms and neurocognitive impairments) can be
observed in 20 percent to 50 percent of relatives of schizophrenia
patients; however, schizotaxia does not always evolve into the
schizotypy, considering that only about 10 percent of adult family
members of schizophrenia patients will became psychotic, and
less than 10 percent will develop schizotypal personality disorder
(Faraone et al., 2001; Kendler, 1985; Kendler et al., 1991; Olin &
Mednick, 1996; Siever, Bergman & Keefe, 1995; Siever et al.,
2002; Torgensen, 1985). These figures suggest that schizotaxia
does not lead inevitably to schizophrenia or schizotypal
personality disorder.
According to Faraone et al. (2001), schizotaxia and schizotypal
personality disorder sometimes co-occur, but the lack of complete
overlap between the two categories illustrates the concept that
schizotaxia is a broader construct than the subset of schizotypal
persons who have predominantly negative symptoms. The
possibility that the genes predisposing to schizotaxia and
schizotypal personality disorder may be related to different forms
of schizophrenia is also suggested.
Previous research on schizotaxia and schizotypal personality
disorder gave rise to several prevention strategies that are currently
being used for early identification and treatment of vulnerable
subjects, describing signs of emerging disorders, such as high-risk
mental state features, attenuated or low grade psychotic symptoms,
or a strong family history of psychotic disorder, in conjunction with
a marked decrease in functioning (Birchwood, McGorry &
Jackson, 1997; Johannenssen, Larsen, McGlashan & Vaglum,
2000; McGlashan, Miller & Woods, 2001; McGorry et al., 1996).
Behavioural-cognitive and pharmacotherapy approaches are used
aimed at helping schizotaxic individuals; which implies that
clinical manifestations of schizotaxia may be amenable to
treatment before they develop further into a psychotic disorder.
Assuming a dimensional view of liability to schizophrenia, as it
was supported by multigenic models of heredity of this disorder, it
is likely that the interaction of multiple genes and environmental
factors are necessary to explain its etiology; which phenotypically
could be expressed through a low, average, or high frequency of
risk markers. Individuals showing high risk markers would be
particularly prone to schizophrenia, whereas individuals having
moderate levels of risk factors would be prone to some other less
severe but related disorders, such as the schizotypy personality
disorder or schizotaxia. The multidimensional nature of schizotypy
could also make possible the existence of «healthy schizotypes»
with functional behaviour in spite of some anomalous
characteristics or experiences (McCreey & Claridge, 2002).
The studies listed above provide abundant support for the
validity of schizotaxia as a theoretical construct that represents
both a clinical meaningful condition and a risk factor for
subsequent psychosis, but they do not validate schizotaxia as a
specific syndrome. For that purpose, Tsuang et al. (2000) recently
developed some tentative research criteria for schizotaxia based
on the combination of negative symptoms and neuropsychological
deficits of at least moderate severity. It is their contention that
negative symptoms could be defined as six scores of 3 or higher
on items of the SANS (Andreasen, 1983); and neuropsychological
impairment could be defined as two standard deviation below
appropriate norms in one cognitive domain (including tests of
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attention/working memory, long-term verbal declarative memory,
and executive functions), and at least one standard deviation
below normal in a second domain.
The foregoing discussion has served to introduce three issues to
be examined in this paper. The first concerns the relationship
between schizotypy and neurocognitive functions in two adult and
adolescent samples. It is hypothesised that significant
neuropsychological deficits should be detected in subjects with
high negative schizotypy, as compared with those with low
negative schizotypy. Evidence suggests that subjects with
schizophrenia spectrum disorders have deficits in executive
functions (Lenzenweger, 1994; Lenzenweger & Korfine, 1995;
Lenzenweger, Loranger, Korfine & Neff, 1997; Rawlings &
Goldberg, 2001). The second question is about the relationship
between genetic and psychosocial risk factors and neurocognitive
functions. The study aimed to test the hypothesis that subjects with
genetic and psychosocial risk factors of schizophrenia spectrum
disorders will also show significantly more deficits in executive
functions. To summarise, the third hypothesis that emerged from
these analyses was that negative schizotypy and neurocognitive
deficits could be useful features for the identification of schizotaxic
subjects. Analysing the relationship between negative symptoms
and neurocognitive deficits, it is proposed a combined measure as
tentative criterion for identification of schizotaxic individuals. 
Method
Participants
A total of 125 participants entered the study, divided into two
samples of 60 adults and 65 adolescents. Normal and genetic or
psychosocial risk groups were identified in each sample. The
adult sample was made of 34 first-degree relatives of patients
with schizophrenia (29 of them were siblings, and 5 parents and
descendants), drawn from psychiatric units and family
associations, and 26 relatives of non-psychotic patients. Of the
total subjects, 38.3% were males (n= 23) and 61,7% were females
(n= 37), aged between 18 and 59 years (Mean= 29.7; SD= 9.8).
There were no significant differences between the two groups in
terms of either age (F= 0.38, p= .54) or gender distribution (χ2=
0.48, p= 0.49).
The children and adolescents sample was made of 65 subjects,
56.9% were males (n= 37) and 43.1% females (n= 28) aged
between 8 and 18 years (Mean= 12.71; SD= 1.78), selected at
random from supposedly differentiated populations, thus allowing
the formation of two subgroups: a normal group, made up of 38
primary and secondary school children, and a psychosocial risk
group made up of 27 residents in foster homes, aged between 8 and
18 years (Mean= 12.8; SD= 2.0). Genetic information was not
available in the adolescents’ sample; however, from a theoretical
point of view, it is assumed that the two subgroups of subjects
might be different in terms of risk of developing psychological
disorders, if we take into account the psychosociological
background, particularly higher family psychosocial problems and
a greater number of environmental stressors, of the so-called risk
group. Nevertheless, the two subgroups are relatively similar in
terms of educational level and type of school attended (all state
schools). There were no significant differences between the two
subgroups in terms of either age (F= 0.11, p= 0.74) or gender
distribution ( χ2= 1.20, p= 0.55).
Measures
1. As a measure of psychometric schizotypy we used for each
sample the following scales: (a) Adult subjects were
administered an Spanish version of the Oxford-Liverpool of
Feelings and Experiences (O-LIFE) (Mason, Claridge &
Jackson, 1995), comprising four subscales of Unusual
experiences, Cognitive disorganisation, Introvertive
anhedonia, and Impulsive non-conformity. (b) Adolescents
were administered a Spanish version of the Multidimensional
Schizotypal Traits Questionnaire (MSTQ) (Rawlings and
MacFarlane, 1994). This research team carried out a factorial
analysis of the items making up the scale, obtaining the
following three subscales: Positive schizotypy (which refers
to characteristics of reality distortion, such as magical
ideation, unusual perceptions and reference ideas); Negative
schizotypy (referring to patterns of social isolation, anhedonia
and restricted affect); and Impulsive non-conformity
(referring to characteristics of impulsive-type personality,
social anxiety and maladjusted behaviours) (Martínez Suárez
et al., 1997).
2. Neurocognitive measures were selected to assess cognitive
functioning:
2.1. Two neuropsychological tests for assessing frontal
executive functions: concepts formation, mental
flexibility and planning, in the versions included in the
STIM software package (provided by NeuroScan
Technical Center, Inc.): (a) Stroop Test (Stroop, 1935),
with the successive random presentation of 100 verbal
stimuli in the form of words denoting four colours.
Presentation of stimuli was carried out with a duration
for each stimulus of 100 ms and a 1 s interstimulus
interval. Four measures were obtained: number of
correct responses, number of time outs, reaction time
for congruent stimuli and reaction time for incongruent
stimuli. (b) Wisconsin Card Sorting Test (WCST)
(Heaton, 1981). Measures recorded were number of
correct responses, number of errors and number of
categories completed.
2.2. Two memory tasks developed by this research team
(Lemos-Giráldez, Inda-Caro, López-Rodrigo, Paíno-
Piñeiro & Besteiro-González, 2000): (a) Word
Recognition Test (Test de Reconocimiento de Palabras,
TRP), based on the concept of reality monitoring, an
experimental paradigm related to self-awareness and
described by Johnson and Raye (1981). The use of this
paradigm, which refers to those processes the
individual uses for discriminating between an internal
stimulus source and an external source, is supported by
the assumption that schizotypal people may also have a
tendency to make attributional errors of this type (Frith,
1992). The task comprises two distinct phases: in the
first, a series of 30 words is presented on the computer
screen and the subject is asked to write, for each one,
another word conceptually related to it, thus forming a
pair (for example, family-father). The subject must
write the word on the keyboard, but without visual
feedback of it on the screen as s/he writes it. Carrying
out this task without this visual feedback, demanding
that the person simply stores the memory at a central,
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self-awareness level, has been shown to be an
experimental condition that hinders its execution in
schizophrenic patients. In the second phase, which
takes place approximately 30 minutes after completion
of the first without prior warning, all the words (those
generated by the computer programme and those
generated by the subject) are presented successively in
random order, and the subject is asked to identify their
origin (external or internal).Two different types of error
are recorded, corresponding to the source to which the
words are attributed: internal attribution errors (when a
word generated by the subject is attributed to the
computer, that is, a self-generated word is considered
hetero-generated), and external attribution errors (when
a word initially generated by the computer is identified
as being produced by the subject). (b) Visual Test of
Working Memory (Prueba Visual de Memoria
Operativa, PVMO), designed for assessing functional
memory through the use of visual stimuli (a series of
computer screens presented with green or blue circles
distributed in different ways). The subject must count
the number of green circles that appear in each screen
presentation. At a given moment, s/he is asked to recall
the number of green circles in each of the screens. The
difficulty level of the task increases progressively as
the number of screens the person has to remember
rises. Number of errors were registered.
2.3. A Continuous Performance Test, which was also
included in the STIM package (CONCPT), consisting
of a visomotor task in which the response must be
contingent on the appearance of two successive letters.
In the version used, the subject is presented with 400
stimuli (4 blocks of 100 letters each) in random order,
with a duration for each stimulus presentation of 50 ms
and an interstimulus interval of 1 s. Measures
processed for this study were means of correct
responses (hit-rates), errors of commission (false
alarms), and reaction times expressed in ms.
2.4. Finally, several verbal, motor, and general cognitive
functioning tasks were also administered: Trail Making
Test, parts A and B (Reitan, 1958). 1. In adults: Digit
Symbol subtest from the WAIS. 2. In adolescents: (a)
Verbal Fluency Task, that requires the subject to
produce, in 90 seconds, as many words as possible
beginning with a given letter. Target letters used were
T, P, C and S; (b) Subtests of Similarities, Vocabulary,
Digit Symbol and Block Design from the WISC. 
All tests were administered individually. Tasks from 2.1 to 2.3
were presented on a computer screen and the whole testing
procedure was fully computerized. All stimuli were central on the
computer screen.
Procedure and data analysis
Participants were individually examined on two separate
occasions, the first to complete the questionnaire of schizotypy,
and some days after were scheduled for a second testing session
that included the administration of neuropsychological tasks in a
quiet, comfortable, and conventionally lighted laboratory room of
the Faculty of Psychology. The order of tests and stimulus
presentation was identical for all the subjects.
Before each experimental block, the task was explained and
commenced when the subject could explain the rules to the
examiner. Participants were instructed to respond as quickly and
accurately as possible, and started each block by pressing the
space bar. No feedback about performance was given to any of the
participants during the tasks.
Since our first and second hypotheses focus on group
comparisons, multivariate analyses of variance (MANOVAs) were
also conducted to determine whether there were overall schizotypy
or risk group differences on the neurocognitive measures. If the
overall Wilks’ λ was significant, univariate Fs were computed to
determine group differences on individual neurocognitive
measures. As an index of effect size we report eta square (η2).
When η2 >.15 effects are ‘large’ in magnitude, and when η2 >.06,
effects are ‘medium’.
Concerning the third hypothesis, starting from the descriptive
statistics obtained from the neurocognitive variables, cut-off
score points were selected to establish the threshold of deficit in
the examined functions. Those points were located in the
percentile 80 of each variable (or in the percentile 20, depending
on the orientation of the measure). These percentiles were taken
as cut-off scores points after finding out that they allow to clearly
discriminate those extreme subjects of higher and lower
schizotypy, as we have confirmed in previous studies (Lemos-
Giráldez et al., 2000).
In order to obtain a combined scale of neurocognitive deficit,
the number of variables in which each subject has shown a
deficient performance has been added. This is to say the number
of measures placed in the deficit range (above percentile 80 or
below percentile 20). Taking into account that the total number of
neurocognitive measures was 16 for the adults and 20 for the
adolescents, the corresponding score for the combined deficit
scale could be placed between 0 and 16, or between 0 and 20,
respectively. Finally the relationship between the combined scale
and the scores on the schizotypy scales were analysed.
Results
Schizotypy factors and neurocognitive functions
Correlations between the scales of schizotypy and neurocognitive
measures in adults and adolescents are shown in Table 1.
Based on the scores from O-LIFE or MSTQ subscales, in the
adult or adolescent samples, two groups were formed with those
subjects in the bottom and top 20% of each factor of schizotypy,
which make up the two levels for dependent variables. 
Omnibus MANOVAs revealed no significant group effects
when compared neurocognitive performance of adults in the low
and high levels in each O-LIFE subscale; with Wilks’ λ= .085, p=
.093, in the Unusual Experiences factor (n= 9/13); Wilks’ λ= .227,
p= .161, in the Cognitive Disorganization factor (n= 13/13);
Wilks’ λ= .278, p= .221, in the Introverted Anhedonia factor (n=
13/14); and with Wilks’ λ= .235, p= .328, in the Impulsive Non-
conformity factor (n= 13/11). Neither significant overall
MANOVA results were found when compared neurocognitive
performance of adolescents in the low and high levels in the
MSTQ subscales of Positive Schizotypy (Wilks’ λ= .248, p= .325,
n= 15/15) and of Impulsive Non-conformity (Wilks’ λ= .612, p=
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.730, n= 25/20). On the contrary, as expected, MANOVA results
revealed significant when compared adolescents with low and
high Negative Schizotypy (Wilks’ λ= .183, p= .026 (n= 18/16).
We therefore examined each of the neurocognitive measures using
univariate ANOVAs. These analyses revealed significant group
differences with respect to the variables described in Table 2.
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Table 1
Correlation between dimensions of schizotypy and neurocognitive measures
Adults (n= 60) Adolescents (n= 65)
Variables Unusual Cognitive Introverted Impulsive non- Positive Negative Impulsive non-
experiences disorganization anhedonia conformity schizotypy schizotypy conformity
TMT-A Time in secs. -.120** -.140 -.053* -.265* -.097* -.046** -.047*
TMT-B Time in secs. -.022** -.137 -.101* -.047* -.080* -.267** -.102*
Stroop:
No. correct responses -.169** -.071 -.293* -.009* -.157* -.224** -.090*
Time-outs -.091** -.057 -.013* -.218* -.055* -.180** -.143*
RT congruent stimuli -.115** -.239 -.026* -.134* -.162* -.260** -.003*
RT incongruent stimuli -.027** -.019 -.010* -.233* -.106* -.226** -.111*
CPT:
Correct responses -.003** -.043 -.025* -.117* -.043* -.217** -.197*
Errors of commission -.006** -.064 -.254* -.108* -.083* -.168** -.011*
Reaction time -.044** -.253 -.119* -.108* -.056* -.235** -.083*
WCST:
Correct responses -.293** -.163 -.075* -.031* -.043* -.299** -.116*
Errors -.115** -.048 -.149* -.084* -.087* -.218** -.050*
Categories completed -.326** -.173 -.053* -.037* -.042* -.284** -.106*
TRP:
Internal attribution errors -.042** -.220 -.071* -.014* -.087* -.146** -.052*
External attribution errors -.078** -.191 -.010* -.029* -.219* -.185** -.184*
PVMO errors -.149** -.101 -.243* -.101* -.035* -.329** -.001*
WAIS: Digit Symbol -.394** -.084 -.069* -.319*
Verbal Fluency -.035* -.200** -.120*
WISC: Similarities -.061* -.354** -.123*
WISC: Vocabulary -.281* -.417** -.022*
WWISC: Block Design -.137* -.182** -.265*
WWISC: Digit Symbol -.303* -.452** -.140*
* <0.05; ** <0.01
Table 2
Results of ANOVAs comparing neurocognitive performance of the groups in the bottom and top 20% of the MSTQ negative schizotypy subscale
Variables Low Negative High Negative F p η2
Schizotypy (n= 18) Schizotypy (n= 16)
TMT-B Time in secs. 83.72 (25.01) 117.75 (36.80) 10.142 .003 .241
Stroop: No. correct responses 74.96 (26.12) 57.52 (21.24) 4.080 .052 .113
Stroop: RT for congruent stimuli 807.34 (83.20) 622.85 (270.47) 7.594 .010 .192
Stroop: RT for incongruent stimuli 849.35 (79.25) 689.75 (253.58) 6.445 .016 .168
WCST: Correct responses 57.67 (4.45) 52.19 (10.85) 3.874 n.s. (.058) .108
WCST: Categories completed 5.67 (.59) 5.00 (1.32) 3.765 n.s. (.061) .105
TRP: External attribution errors 5.22 (2.80) 8.00 (4.77) 4.402 .044 .121
PVMO errors 11.94 (7.04) 21.13 (8.66) 11.604 .002 .266
WISC: Similarities 13.00 (3.22) 9.75 (4.23) 6.434 .016 .167
WISC: Vocabulary 10.56 (3.63) 5.81 (3.75) 14.022 .001 .305
WISC: Digit Symbol 12.78 (2.88) 9.00 (3.31) 12.679 .001 .284
Risk factors and neurocognitive functions
The comparison between first-degree relatives of non-psychotic
patients and of patients with schizophrenia (low vs. high genetic
risk), in the adult sample, revealed no significant differences in
neurocognitive measures (Wilks’ λ= .642, p= .214) or in the O-
LIFE subscales (Wilks’ λ= .945, p= .545); but as shown in Table 3,
when compared adolescents with low and high psychosocial risk in
the first MANOVA analytic step there were significant risk-group
differences in either neurocognitive performance (Wilks’ λ= .448,
p= .015) or schizotypy subscales (Wilks’ λ= .826, p= .009).
Univariate Fs revealed significant differences in neurocognitive
measures and schizotypy scales in the expected directions.
A combined measure of schizotaxia
Table 4 shows all the variables used in the composition of the
combined scale of the neurocognitive deficit, with the cut-off
scores corresponding to percentiles 80 or 20, and the number of
subjects which fall above or below those scores (criterion subjects).
Considering the neurocognitive measures as a whole, the results
reveal that 13,56% of the adults and 12% of the adolescents fall
within the deficit range. 
Bivariate Pearson’s correlations between the combined scale of
the neurocognitive deficit and the scores obtained in each of the
scales of the schizotypy survey were carried out with all the
subjects of each subgroup. In the sample of adults, a statistically
significant correlation was found between the combined scale of
neurocognitive deficit and the scale of Introvertive Anhedonia of
the O-LIFE (r= .229, p= .048). The correlations with the other
three scales of this survey were much lower: Unusual Experiences
(r= .004, p= .978), Cognitive Disorganisation (r= .206, p= .120)
and Impulsive Non-conformity (r= -.129; p= .335).
In the sample of adolescents, the correlation between the
combined scale of the neurocognitive deficit and the subscales of
schizotypy reached higher statistical significance with Negative
Schizotypy of the MSTQ (r= .504, p= .000), while the correlations
with the scales of Positive Schizotypy (r= .144, p= .298) and
Impulsive Non-conformity (r= -.117, p= .400) were not significant.
Consequently, the results indicate the existence of a significant
relationship exclusively between the neurocognitive deficit and
the negative traits of schizotypy, both in adults and in adolescents. 
In order to stress this relationship and at the same time finetune
the cut-off scores which best discriminate the observed relationship
between both variables, Contingency Analyses were carried out
comparing different cut-off scores on the combined scale of
neurocognitive deficit and on the scale of negative schizotypy. To
this purpose, three cut-off scores on the scales of negative
schizotypy and four cut-off scores on the scale of combined deficit
were separately fixed for adults and adolescents, so to determine
which are the levels that represent the best decision criterion on
theoretical vulnerability. One point was given when the subject
scored in the ranges below the cut-off score and two points were
assigned when scored in the ranges above the cut-off score. Table
5 features the results of these analyses. 
These results indicate that, in the sample of adults, the cut-off
scores which best maximise the differences between the scale of
Introverted Anhedonia and the combined scale of the
neurocognitive deficit correspond to the ranges 1-89 and 90 or
above in the percentiles of the O-LIFE, and of 0-5 and 6 or more
points on the scale of the 16 measures of the neurocognitive deficit.
This relationship shows a tendency towards the statistic significance
(p= .064). Consequently, from a theoretical point of view, one can
hypothesise that the subjects presenting a score on the subscale of
Introverted anhedonia equivalent to percentile 90 or above, while
the score on the combined scale of neurocognitive deficit is equal to
5 or above, would run a high risk of developing some kind of
psychotic disorder. Of the total of 65 participants of the adult group,
14 subjects which meet both criteria were identified, which,
consequently, could be considered schizotaxic. Of these 14
hypothetically schizotaxic subjects, 9 were relatives of patients with
schizophrenia (genetic risk), and 5 belonged to the normal group. 
In the sample of adolescents, the Contingency analyses reveal
that the cut-off scores that best maximise the difference between
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Table 3
Results of ANOVAs comparing neurocognitive performance of adolescents with low or high psychosocial risk
Variables Low risk High risk F p η2
(n= 38) (n= 27)
TMT-B Time in secs. 90.74 (27.59) 130.30 (54.32) 12.699 .001 .054
Stroop: RT for incongruent stimuli 708.25 (210.57) 554.40 (241.44) 3.361 n.s. (.072) .057
CPT: Correct responses 14.13 (1.89) 13.06 (1.85) 4.648 .035 .077
WCST: Correct responses 56.61 (6.66) 51.85 (10.19) 4.547 .037 .075
WCST: Errors of commission 46.32 (19.83) 58.44 (20.49) 5.227 .026 .085
WCST: Categories completed 5.52 (.89) 4.93 (1.24) 4.427 .040 .073
TRP: Internal attribution errors 6.39 (4.31) 10.52 (7.09) 7.392 .009 .117
PVMO errors 13.97 (7.94) 20.93 (10.96) 7.796 .007 .112
WISC: Similarities 12.61 (3.58) 9.00 (3.69) 14.267 .000 .203
WISC: Vocabulary 10.65 (3.95) 5.15 (3.56) 30.582 .000 .353
WISC: Digit Symbol 12.29 (3.17) 8.70 (3.02) 19.251 .000 .256
MSTQ: Negative schizotypy 2.05 (1.86) 3.67 (1.75) 12.343 .001 .166
the scale of Negative Schizotypy of MSTQ and the combined
scale of the neurocognitive deficit correspond to the ranges 1-84
and 85 or more in the percentiles of this subscale, and from 0-5
and 6 or more in the combined scale of 20 measures of the
neurocognitive deficit. The relation between both cut-off scores
was highly significant (p= .005). Therefore we could, from a
theoretical point of view, hypothesise that a subject is schizotaxic
when s/he presents a score equivalent to a percentile of 85 or
above on the Negative schizotypy scale, and at the same time a
score that is equal to or above 6 in the combined scale of
neurocognitive deficit. In the adolescents’ group, 14 out of the 60
participants meet both criteria, 11 of which belong to the subgroup
of psychosocial risk (living in foster homes).
Discussion
In the present study, we compared neurocognitive measures and
dimensions of schizotypy in an attempt to confirm a priori
hypotheses about the relationship between cognitive deficits and
negative schizotypy. As expected, our results confirm, in bivariate
correlation analyses, that a specific and significant relationship exists
between cognitive deficit and negative schizotypy. However, this
relationship was stronger in the adolescent sample than in adults.
When compared subjects scoring in the bottom with those scoring in
the top 20% of the schizotypy scales, more significant relationship
emerged in the adolescent sample but not in adult subgroups, which
could be due to a low sensitivity of the O-LIFE subscales.
We had also hypothesised that subjects with genetic and
psychosocial risk factors of schizophrenia spectrum disorders will
also show significantly more deficits in executive functions. The
data reported here confirmed that it was true in the adolescents
sample but, again, this hypothesis was not supported in adults.
These unexpected finding, again, raise questions about the
translation of the given MSTQ factorial structure to our culture. 
The purpose of the third part of this study coincide with those of
other authors in identifying those persons with schizotaxic
characteristics. Schizotaxia is still an evolving concept, not a
disorder with set criteria, although operationalized research criteria
for schizotaxia were proposed on the basis of a combination of
negative symptoms and neurocognitive deficits, two areas that have
been the focus of the most robust findings in first-degree relatives
of patients with schizophrenia (Tsuang et al., 2000; Tsuang et al.,
2002).
In previous studies, carried out with clinical and normal
populations, a clear relationship between schizotypic symptoms
and cognitive dysfunctions (Lenzenweger, 1994; Lenzenweger &
Korfine, 1995; Lenzenweger et al., 1997; Rawlings & Goldberg,
2001) has been found; therefore one of the most useful aspects for
the clinical assessment and the early detection of risk subjects is to
have at our disposal a measure that simplifies the process of
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Table 4
Variables in the combined scale, cut-off scores, and subjects scoring in the top 80 percent and bottom 20 percent of the distribution of scores
Adults (n= 60) Adolescents (n= 65)
Variables Top and bottom Cut-off score No. of criterion Cut-off score No. of criterion
percent subjects subjects
TMT-A Time in secs. 80 49.4 12 65.0 14
TMT-B Time in secs. 80 87.4 12 146.0 11
Stroop:
No. correct responses 20 85.8 12 47.6 11
Time-outs 80 16.8 12 29.2 11
RT for congruent stimuli 80 833.39 13 856.35 11
RT for incongruent stimuli 80 863.26 12 906.36 11
CPT:
Correct responses 20 14.75 24 12.95 11
Errors of commission 80 0.50 20 7.8 11
Reaction time 80 436.87 12 392.97 11
WCST:
Correct responses 20 59.0 8 47.0 12
Errors 80 52.0 12 73.0 12
Categories completed 20 5.0 8 4.0 14
TRP:
Internal attribution errors 80 8.0 13 13.2 11
External attribution errors 80 7.0 13 10.0 16
PVMO errors 80 12.0 12 26.2 11
WAIS: Digit Symbol 20 12.0 22
Verbal Fluency 20 8.0 12
WISC: Similarities 20 7.2 11
WISC: Vocabulary 20 3.2 11
WISC: Block Design 20 7.0 14
WISC: Digit Symbol 20 8.0 14
determining the vulnerability to psychotic disorders, given the high
quantity of existing neurocognitive measures. The development of
a combined measure is considered reasonable, since the research
concerning the neurocognitive deficit in schizotypy is in a
sufficiently advanced stage as to select, from all the available tests
and markers, those that best identify the psychometrically
schizotypic subjects. 
Another advantage added to the identification of high-risk
subjects, by means of a combined measure, is that it reinforces the
idea that psychotic signs start before the beginning of the disorder
and psychotic versus nonpsychotic are polar extremes of a
continuum that has intervening shades or gradations. Furthermore,
those subjects with more than one behavioural or neurocognitive
sign or marker of risk could be selected for the study of early
processes of the illness, for the development and the validation of
new vulnerability markers, and for early intervention programs.
The significant correlation exclusively found between negative
schizotypy and neurocognitive functions is consistent with Meehl’s
contention about their common biological relatedness. Flatt affect
and particularly hypohedonia are the result of a heritable
component of pleasure impairment, poligenically determined, and
probably derived from a deviation in the microanatomy or
neurochemistry of the limbic system (Meehl, 2001). The
relationship between negative symptoms of schizotypy and
neurocognitive deficit has been observed in non-clinical samples
(Dinn, Harris, Aycicegi, Greene & Andover, 2002; Kwapil, 1998),
which seems to confirm our findings and the concept of schizotaxia
used by other authors, apart from the presence of other
neuropsychological abnormalities such as the deviation of the
oculomotor tracking impairment and structural brain abnormalities
(Faraone et al., 2001; Tsuang et al., 2002). On the other hand,
family studies show that negative (in particular flat affect and
abulia) but not positive symptoms of schizotypy are significantly
more frequent in the relatives of schizophrenic patients and allow to
differenciate them from the control population (Faraone et al.,
1999; Kendler, Neale & Walsh, 1995; Tsuang et al., 2002).
This study aims at operatively establishing criteria in order to
define schizotaxia combining the negative symptoms with the
neurocognitive deficit, following the recommendations of other
researchers (Cornblatt, Lencz & Obuchowski, 2002; Lencz, Raine,
Benishay, Mills & Bird, 1995; Tsuang et al., 2002), and our results
indicate that it is possible to trace consistent relationships.
However, it is clear that the definition of the criteria of schizotaxia
cannot be constrained exclusively to those of the components
studied here, but it also has to integrate other independent clinical
and of social functioning measures. Supposedly, the schizotaxic
subjects should show poorer clinical or social function (in terms of
signs and symptoms, quality of life, and social adjustment), as
compared to normal population, and these differences must not be
attributable to age, education, IQ, family genetic loading, gender,
SERAFÍN LEMOS GIRÁLDEZ, MERCEDES PAÍNO PIÑEIRO, MERCEDES INDA CARO AND JOSÉ LUIS BESTEIRO GONZÁLEZ306
Table 5
Results of the Contingency Analyses comparing several ranges below and over cut-off percentiles in negative schizotypy scales and scores in the combined scale of
neurocognitive deficit
Cut-off percentiles in Cut-off scores in the Contingency p
Introvertive anhedonia (O-LIFE) combined deficit scale Coefficient
Adults 1-79/80+ 0-7/8+ 0.00 1.00
0-6/7+ 0.00 1.00
0-5/6+ 1.18 0.28
0-4/5+ 0.49 0.22
1-84/85+ 0-7/8+ 0.00 1.00
0-6/7+ 0.00 1.00
0-5/6+ 1.18 0.28
0-4/5+ 0.49 0.22
1-89/90+ 0-7/8+ 2.42 0.12
0-6/7+ 2.42 0.12
0-5/6+ 1.57 0.21
0-4/5+ 3.42 .064
Cut-off percentiles Cut-off scores in the Contingency p
in Negative schizotypy (MSTQ-N) combined deficit scale Coefficient
Adolescents 1-79/80+ 0-7/8+ 5.134 .023
0-6/7+ 5.134 .023
0-5/6+ 5.196 .023
0-4/5+ 3.243 .072
1-84/85+ 0-7/8+ 5.845 .016
0-6/7+ 5.845 .016
0-5/6+ 7.912 .005
0-4/5+ 5.750 .016
1-89/90+ 0-7/8+ 2.101 .147
0-6/7+ 2.101 .147
0-5/6+ 2.427 .119
0-4/5+ 1.601 .206
or co-morbidity psychiatric disorders. Accordingly, to validate the
proposed criteria for schizotaxia and support the syndrome,
converging evidence from multiple domains is necessary. 
Nevertheless it must be pointed out that with the two
characteristics here studied, a 21,54% of the potentially schizotaxic
subjects has been identified, in the sample of adults, 64,29% of
them belonging to relatives of schizophrenic patients. In the sample
of adolescents, of whose family morbidity there is no information
available, 23,33% of the sample are identified as schizotaxic, out of
which 78,57% belong to the group living in foster homes. These
data do not differ from those obtained by Faraone et al., as they
observed neuropsychological deficits or negative symptoms in 20-
50% of non-psychotic relatives in family studies (Faraone, Kremen
et al., 1995; Faraone, Seidman et al., 1995).
In keeping with Tsuang et al. (2002), the results of our study
indicate that a good procedure to determine that a subject shows
some risk of developing psychotic disorders could be the
combination, on one hand, of negative symptoms of schizotypy and,
on the other hand, of the neurocognitive deficit in the prefrontal
cognitive functions (in our study measured by means Stroop and
WCST tasks), memory (measured with TRP and PVMO tests),
attention (measured with CPT), and executive functions (assessed
with TMT, verbal fluency and subtests of WAIS or WISC).
Consequently, the methods employed in this study show that it is
possible to obtain a more precise measure of identifying adolescent
and adult subjects which are more vulnerable to psychotic disorders.
Furthermore, our results reveal that a broad number of subjects
theoretically defined as «risk groups» due to the presence of genetic
or environmental factors, display high scores in the measure derived
from schizotaxia, which means that the theoretical value of that
measure correlates to the presence of family morbidity and/or
psychosocial risk factors.
Finally, although there is preliminary evidence that lends
credibility to our proposal, a caution is needed regarding the
predictive value of the combined measure of schizotaxia presented
in this study. We would like to stress that it will be necessary to
obtain converging follow-up evidence from multiple domains, by
comparing subjects who met our criteria for schizotaxia with those
who did not do so in independent measures of social functioning
and clinical outcome.
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